MedTrace Logo

INTERPRET - International Report on Routine Practice of Sensor-enabled Pump Therapy

NCT00790088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 274

Last updated 2019-02-20

Study results available
· View outcomes & findings →

Summary

The aim of the project is to document the international routine practice in sensor usage in patients treated with sensor-augmented pump therapy and to assess which variables (e.g. training of patients, frequency of sensor usage etc) are associated with an improvement in clinical outcome(s) from the start of the sensor use to the end of the follow-up period.

Conditions

  • Diabetes Mellitus, Type 1

Sponsors & Collaborators

  • Medtronic Diabetes

    lead INDUSTRY

Principal Investigators

  • Ohad Cohen, Prof · Chaim Sheba Medical Center, Tel Hashomer, Israel

  • Kirsten Noergaard, MD · Hvidovre Hospital, Hvidovre, Denmark

  • Andrea Scaramuzza, MD · Sacco Hospital, University of Milan, Italy

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-03-31
Completion
2012-05-31

Countries

  • Austria
  • Belgium
  • Denmark
  • France
  • Hungary
  • Israel
  • Italy
  • Lithuania
  • Poland
  • Serbia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00790088 on ClinicalTrials.gov